Johnson & Johnson (JNJ)

USD 156.12

(1.07%)

Revenue Summary of Johnson & Johnson

  • Johnson & Johnson's latest annual revenue in 2023 was 85.15 Billion USD , up 6.46% from previous year.
  • Johnson & Johnson's latest quarterly revenue in 2024 Q3 was 22.47 Billion USD , up 0.11% from previous quarter.
  • Johnson & Johnson reported a annual revenue of 79.99 Billion USD in annual revenue 2022, up 1.59% from previous year.
  • Johnson & Johnson reported a annual revenue of 78.74 Billion USD in annual revenue 2021, down -4.65% from previous year.
  • Johnson & Johnson reported a quarterly revenue of 21.38 Billion USD for 2024 Q1, down -0.06% from previous quarter.
  • Johnson & Johnson reported a quarterly revenue of 22.44 Billion USD for 2024 Q2, up 4.98% from previous quarter.

Annual Revenue Chart of Johnson & Johnson (2023 - 1989)

Historical Annual Revenue of Johnson & Johnson (2023 - 1989)

Year Revenue Revenue Growth
2023 85.15 Billion USD 6.46%
2022 79.99 Billion USD 1.59%
2021 78.74 Billion USD -4.65%
2020 82.58 Billion USD 0.64%
2019 82.05 Billion USD 0.59%
2018 81.58 Billion USD 6.71%
2017 76.45 Billion USD 6.34%
2016 71.89 Billion USD 2.59%
2015 70.07 Billion USD -5.73%
2014 74.33 Billion USD 4.23%
2013 71.31 Billion USD 6.08%
2012 67.22 Billion USD 3.37%
2011 65.03 Billion USD 5.59%
2010 61.58 Billion USD -0.5%
2009 61.89 Billion USD -2.9%
2008 63.74 Billion USD 4.34%
2007 61.09 Billion USD 14.57%
2006 53.32 Billion USD 5.56%
2005 50.51 Billion USD 6.69%
2004 47.34 Billion USD 13.1%
2003 41.86 Billion USD 15.33%
2002 36.29 Billion USD 9.98%
2001 33 Billion USD 13.26%
2000 29.13 Billion USD 6.07%
1999 27.47 Billion USD 16.12%
1998 23.65 Billion USD 4.54%
1997 22.62 Billion USD 4.67%
1996 21.62 Billion USD 14.74%
1995 18.84 Billion USD 19.75%
1994 15.73 Billion USD 11.29%
1993 14.13 Billion USD 2.8%
1992 13.75 Billion USD 10.49%
1991 12.44 Billion USD 10.82%
1990 11.23 Billion USD 15.12%
1989 9.75 Billion USD 8.41%

Peer Revenue Comparison of Johnson & Johnson

Name Revenue Revenue Difference
AbbVie Inc. 54.31 Billion USD -56.779%
Bristol-Myers Squibb Company 45 Billion USD -89.217%
Bristol-Myers Squibb Company Ce 45 Billion USD -89.217%
Eli Lilly and Company 34.12 Billion USD -149.557%
Merck & Co., Inc. 60.11 Billion USD -41.66%
Novartis AG 46.66 Billion USD -82.51%
Organon & Co. 6.26 Billion USD -1259.716%
Pfizer Inc. 58.49 Billion USD -45.581%